Studies have found that TRIP13, as MRGs, constructs the prognostic characteristics of multiple myeloma and can be used as a prognostic marker for multiple myeloma (Lv and Zhang, 2024). The gene discussed is TRIP13; the disease is plasma cell myeloma.